LYTIR

Insider · SEC Form 4 · President and COO

Julie Rubinstein

Filed with the SEC as RUBINSTEIN JULIE; the order above is the one the filer's own signature uses.

In the 12 months to Nov 19, 2026, on the open market: sold $10.2M of ADPT. Filed a median of 1 business day after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $10.2M in total.Oct: Insider sales $6.9MNov: Insider sales $3.3MDecJanFebMarAprMayJunJulAugSepOctNov$6.9M
Insider purchases above the line: $0Insider sales below: $10.2M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. ADPTSold: Adaptive Biotechnologies Corp Nov 13, 2026 11,466 shares filed Nov 13, 2026 377,802 shares held directly after, as filed 10b5-1 plan filing $332K
  2. ADPTSold: Adaptive Biotechnologies Corp Nov 12, 2026 11,881 shares filed Nov 13, 2026 377,802 shares held directly after, as filed 10b5-1 plan filing $349K
  3. ADPTSold: Adaptive Biotechnologies Corp Nov 11, 2026 11,881 shares filed Nov 13, 2026 2 transactions 10b5-1 plan filing $366K
  4. ADPTSold: Adaptive Biotechnologies Corp Nov 10, 2026 11,881 shares filed Nov 10, 2026 2 transactions 10b5-1 plan filing $351K
  5. ADPTSold: Adaptive Biotechnologies Corp Nov 9, 2026 11,881 shares filed Nov 10, 2026 3 transactions 10b5-1 plan filing $358K
  6. ADPTSold: Adaptive Biotechnologies Corp Nov 6, 2026 11,881 shares filed Nov 6, 2026 2 transactions 10b5-1 plan filing $327K
  7. ADPTSold: Adaptive Biotechnologies Corp Nov 5, 2026 11,881 shares filed Nov 6, 2026 3 transactions 10b5-1 plan filing $315K
  8. ADPTSold: Adaptive Biotechnologies Corp Nov 4, 2026 11,881 shares filed Nov 6, 2026 2 transactions 10b5-1 plan filing $313K
  9. ADPTSold: Adaptive Biotechnologies Corp Nov 3, 2026 11,881 shares filed Nov 3, 2026 377,802 shares held directly after, as filed 10b5-1 plan filing $309K
  10. ADPTSold: Adaptive Biotechnologies Corp Nov 2, 2026 11,881 shares filed Nov 3, 2026 2 transactions 10b5-1 plan filing $303K
  11. ADPTSold: Adaptive Biotechnologies Corp Oct 30, 2026 11,881 shares filed Nov 3, 2026 2 transactions 10b5-1 plan filing $318K
  12. ADPTSold: Adaptive Biotechnologies Corp Oct 29, 2026 11,881 shares filed Oct 29, 2026 377,802 shares held directly after, as filed 10b5-1 plan filing $336K
  13. ADPTSold: Adaptive Biotechnologies Corp Oct 28, 2026 11,881 shares filed Oct 29, 2026 2 transactions 10b5-1 plan filing $338K
  14. ADPTSold: Adaptive Biotechnologies Corp Oct 27, 2026 11,881 shares filed Oct 29, 2026 2 transactions 10b5-1 plan filing $324K
  15. ADPTSold: Adaptive Biotechnologies Corp Oct 26, 2026 11,881 shares filed Oct 26, 2026 2 transactions 10b5-1 plan filing $309K
  16. ADPTSold: Adaptive Biotechnologies Corp Oct 23, 2026 11,881 shares filed Oct 26, 2026 2 transactions 10b5-1 plan filing $297K
  17. ADPTSold: Adaptive Biotechnologies Corp Oct 22, 2026 11,881 shares filed Oct 26, 2026 2 transactions 10b5-1 plan filing $291K
  18. ADPTSold: Adaptive Biotechnologies Corp Oct 21, 2026 11,881 shares filed Oct 21, 2026 2 transactions 10b5-1 plan filing $302K
  19. ADPTSold: Adaptive Biotechnologies Corp Oct 20, 2026 11,881 shares filed Oct 21, 2026 2 transactions 10b5-1 plan filing $291K
  20. ADPTSold: Adaptive Biotechnologies Corp Oct 19, 2026 11,881 shares filed Oct 21, 2026 377,802 shares held directly after, as filed 10b5-1 plan filing $286K
  21. ADPTSold: Adaptive Biotechnologies Corp Oct 16, 2026 11,881 shares filed Oct 16, 2026 2 transactions 10b5-1 plan filing $288K
  22. ADPTSold: Adaptive Biotechnologies Corp Oct 15, 2026 11,881 shares filed Oct 16, 2026 377,802 shares held directly after, as filed 10b5-1 plan filing $304K
  23. ADPTSold: Adaptive Biotechnologies Corp Oct 14, 2026 11,881 shares filed Oct 16, 2026 2 transactions 10b5-1 plan filing $305K
  24. ADPTSold: Adaptive Biotechnologies Corp Oct 13, 2026 11,881 shares filed Oct 13, 2026 377,802 shares held directly after, as filed 10b5-1 plan filing $303K
  25. ADPTSold: Adaptive Biotechnologies Corp Oct 12, 2026 11,881 shares filed Oct 13, 2026 2 transactions 10b5-1 plan filing $303K
  26. ADPTSold: Adaptive Biotechnologies Corp Oct 9, 2026 11,881 shares filed Oct 13, 2026 377,802 shares held directly after, as filed 10b5-1 plan filing $314K
  27. ADPTSold: Adaptive Biotechnologies Corp Oct 8, 2026 11,881 shares filed Oct 8, 2026 377,802 shares held directly after, as filed 10b5-1 plan filing $305K
  28. ADPTSold: Adaptive Biotechnologies Corp Oct 7, 2026 11,881 shares filed Oct 8, 2026 377,802 shares held directly after, as filed 10b5-1 plan filing $314K
  29. ADPTSold: Adaptive Biotechnologies Corp Oct 6, 2026 11,881 shares filed Oct 8, 2026 4 transactions 10b5-1 plan filing $330K
  30. ADPTSold: Adaptive Biotechnologies Corp Oct 5, 2026 11,881 shares filed Oct 5, 2026 2 transactions 10b5-1 plan filing $347K
  31. ADPTSold: Adaptive Biotechnologies Corp Oct 2, 2026 11,881 shares filed Oct 5, 2026 377,802 shares held directly after, as filed 10b5-1 plan filing $334K
  32. ADPTSold: Adaptive Biotechnologies Corp Oct 1, 2026 11,881 shares filed Oct 5, 2026 2 transactions 10b5-1 plan filing $333K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.

Planned sales (Form 144)

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Notices filed under this filer's SEC CIK in the same 12 months, newest first; the figure is the market value the notice states. Not every notice becomes a sale. Every recent notice

  1. ADPTJULIE RUBINSTEIN filed Oct 1, 2026 Adaptive Biotechnologies Corp Officer 379,777 shares planned sale date 10/01/2026 filing $11.0M

Other Form 4 entries

Not counted above: entries this filer reported on Form 4 in the same 12 months that are not open-market purchases or sales. Each entry is one line of a filing.

  • ADPT: option exercise or conversion (code M), 32 entries, Oct 1 to Nov 13, 2026
Code M
An exercise or conversion of a derivative security received from the company, such as stock options.

Source: the same SEC Form 4 filings. The codes are the SEC's own transaction codes; the meanings above are a plain-words reading of the SEC's Form 4 instructions.